NS · Pharmaceuticals

Aarti Pharmalabs Ltd (AARTIPHARM)

Pharmaceuticals & Biotechnology

Aarti Pharmalabs Ltd (AARTIPHARM) is listed on NS in the Pharmaceuticals sector. Industry: Pharmaceuticals & Biotechnology. As of 2026-07-10, reported market cap is $64.10B, P/E ratio is 36.37, net margin is 12.5%, dividend yield is 0.21%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for AARTIPHARM

Market cap

$64.10B

P/E ratio

36.37

Net margin

12.5%

Dividend yield

0.21%

Aarti Pharmalabs Ltd (AARTIPHARM) — FAQ

What is Aarti Pharmalabs Ltd's market cap?

Aarti Pharmalabs Ltd (AARTIPHARM) has a reported market cap of $64.10B (data as of 2026-07-10).

What is AARTIPHARM's P/E ratio?

The price-to-earnings (P/E) ratio for Aarti Pharmalabs Ltd (AARTIPHARM) is 36.37 (data as of 2026-07-10).

Does Aarti Pharmalabs Ltd pay a dividend?

Aarti Pharmalabs Ltd (AARTIPHARM) shows a reported dividend yield of 0.21%. Open the MyAverix Finance app for dividend history and payout details (data as of 2026-07-10).

What sector is Aarti Pharmalabs Ltd in?

Aarti Pharmalabs Ltd (AARTIPHARM) is classified in the Pharmaceuticals sector (Pharmaceuticals & Biotechnology industry).

What exchange is AARTIPHARM listed on?

AARTIPHARM is listed on NS.

What is Aarti Pharmalabs Ltd's net margin?

Aarti Pharmalabs Ltd (AARTIPHARM) reports a net margin of 12.5% (data as of 2026-07-10).

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Pharmaceuticals companies

FDC Ltd (FDC) Strides Pharma Science Ltd (STAR)